Pulmonary arterial hypertension has a poor prognosis quoad vitam et valitudinem. Herein, we report on a middle-aged woman affected by idiopathic pulmonary arterial hypertension whose quality of life and exercise tolerance improved remarkably after a six-month course of treatment with the long-acting phosphodiesterase-5 inhibitor tadalafil.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ijcard.2005.08.051 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!